Statin treatment after a recent TIA or stroke: Is effectiveness shown in randomized clinical trials also observed in everyday clinical practice?

Acta Neurologica Scandinavica

Volumn 122, Issue 1, 2010, Pages 15-20

  Lingsma, H F ^a   Steyerberg, E W ^a   Scholte Op Reimer, W J M ^b   Van Domburg, R ^a   Dippel, D W J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b AMSTERDAM UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

Author keywords

Propensity score; Randomized clinical trials; Statins; Stroke

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL RESEARCH; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; PATIENT COMPLIANCE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

AGED; DATA COLLECTION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ISCHEMIC ATTACK, TRANSIENT; LOGISTIC MODELS; MALE; NETHERLANDS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 77953353803     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2009.01247.x     Document Type: Article

References (24)

1. The Scandinavian Simvastatin Survival Study (4s). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1994 344 : 1383 1389.
2. The Long-Term Intervention With Pravastatin In Ischaemic Disease (lipid) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998 339 : 1349 1357.
3. Colhoun HM, Betteridge DJ, Durrington PN et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004 364 : 685 696.
4. Heart Protection Study Collaborative. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002 360 : 7 22.
5. Plehn JF, Davis BR, Sacks FM et al. Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation 1999 99 : 216 223.
6. Sever PS, Dahlof B, Poulter NR et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003 361 : 1149 1158. (Pubitemid 36398384)
7. Amarenco P, Labreuche J, Lavallee P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 2004 35 : 2902 2909.
8. Goldstein LB, Amarenco P, Bogousslavsky J et al. Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still out. Cerebrovasc Dis 2004 18 : 1 2.
9. Amarenco P, Bogousslavsky J, Callahan A III. et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006 355 : 549 559.
10. Collins R, Armitage J, Parish S, Sleight P, Peto R, Heart Protection Study Collaborative. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004 363 : 757 767.
11. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?" Lancet 2005 365 : 82 93.
12. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002 288 : 455 461.
13. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002 288 : 462 467.
14. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998 17 : 2265 2281.
15. Verschoor H, Stolker DHCM, Franke CL. Stroke services anno 2003. The Hague: Netherlands Heart Foundation, 2004.
16. Lingsma HF, Dippel DW, Hoeks SE et al. Variation between hospitals in patient outcome after stroke is only partly explained by differences in quality of care: results from the Netherlands Stroke Survey. J Neurol Neurosurg Psychiatry 2008 79 : 888 894.
17. Scholte op Reimer WJ, Dippel DW, Franke CL et al. Quality of hospital and outpatient care after stroke or transient ischemic attack: insights from a stroke survey in the Netherlands. Stroke 2006 37 : 1844 1849.
18. Wade DT, Collin C. The Barthel ADL index: a standard measure of physical disability? Int Disabil Stud 1988 10 : 64 7.
19. Simpson CR, Wilson C, Hannaford PC, Williams D. Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care. Stroke 2005 36 : 1771 1775.
20. Richtlijn Diagnostiek, behandeling en zorg voor patiënten met een beroerte, Nederlandse vereniging voor Neurologie, Utrecht 2008. Available at: http//www.cbo.nl/product/richtlijnen/folder20021023121843/rl-beroerte-09.pdf (accessed on 13 July 2009).
21. Ovbiagele B, Saver JL, Fredieu A et al. PROTECT: a coordinated stroke treatment program to prevent recurrent thromboembolic events. Neurology 2004 63 : 1217 1222.
22. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003 326 : 1423.
23. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001 357 : 1191 1194. (Pubitemid 32378696)
24. Schoenfeld PS. Evidence-based medicine in practice: applying intention-to-treat analysis and perprotocol analysis. Am J Gastroenterol 2005 100 : 3 4.